INTRODUCTION
Although all human cells carry out common processes that are essential for survival, in the physical context of their tissue-environment, they also exhibit unique functions that help define their phenotype. These common and tissue-specific processes are ultimately controlled by gene regulatory networks that alter which genes are expressed and control the extent of that expression. While tissue-specificity is often described based on gene expression levels, we recognize that, by themselves, individual genes, or even sets of genes, cannot adequately capture the variety of processes that distinguish different tissues. Rather, biological function requires the combinatorial involvement of multiple regulatory elements, primarily transcription factors (TFs), that work together and with other genetic and environmental factors to mediate the transcription of genes and their protein products [1, 2] .
Gene regulatory network modeling provides a mathematical framework that can summarize the complex interactions between transcription factors, genes, and gene products [3] [4] [5] [6] . Despite the complexity of the regulatory process, the most widely-used network modeling methods are based on pairwise gene co-expression information [7] [8] [9] [10] . While these correlation-based networks may provide * rekrg@channing.harvard.edu; mkuijjer@jimmy.harvard.edu †Equal contribution some biological insight concerning the associations between both tissue-specific and other genes [11, 12] , they do not explicitly model key elements of the gene regulatory process.
PANDA (Passing Attributes between Networks for Data Assimilation) is an integrative gene regulatory network inference method that models the complexity of the regulatory process, including interactions between transcription factors and their targets [13] . PANDA uses a message passing approach to optimize an initial network between transcription factors and target genes by integrating it with gene co-expression and proteinprotein interaction information. In contrast to other network approaches, PANDA does not directly incorporate co-expression information between regulators and targets. Instead, edges in PANDA-predicted networks reflect the overall consistency between a transcription factor's canonical regulatory profile and its target genes' co-expression patterns. A number of studies have shown that analyzing the structure of the regulatory networks estimated by PANDA can help elucidate the regulatory context of genes and transcription factors and provide insight in the associated biological processes [14] [15] [16] [17] .
The transcriptomic data produced by the Genotype-Tissue Expression (GTEx) consortium [18] provide us with an unprecedented opportunity to investigate the complex regulatory patterns important for maintaining the diverse functional activity of genes across different tissues in the human body [19, 20] . These data include high-throughput RNA sequencing (RNA-Seq) informa-tion from 551 research subjects, sampled from 52 postmortem body sites and cell lines derived from two tissue types.
In this study, we apply PANDA to infer gene regulatory networks for thirty-eight different tissues by integrating GTEx RNA-Seq data with a canonical set of transcription factor to target gene edges (based on a motif scan of proximal promoter regions) and protein-protein interactions. We then use these tissue-networks to identify tissue-specific regulatory interactions, to study the tissue-specific regulatory context of biological function, and to understand how tissue-specificity manifests itself within the global regulatory framework. By studying the structure of these networks and comparing them between tissues, we are able to gain several important insights into tissue-specific gene regulation. Our overall approach is summarized in Figure 1 .
RESULTS

Identifying Tissue-Specific Network Edges
We started by reconstructing genome-wide regulatory networks for each human tissue. We downloaded GTEx RNA-Seq data from dbGaP (phs000424.v6.p1, 2015-10-05 release) and preprocessed the data to identify misannotated samples and identify transcriptionally distinct tissues. The RNA-Seq data were normalized in a sparseaware manner [21] so as to retain genes that are expressed in only a single or small number of tissues. After filtering and quality control, our RNA-Seq data included expression information for 27, 175 genes measured across 9, 435 samples and 38 distinct tissues (Supplemental Materials and Methods). For each tissue, we used PANDA to integrate gene-gene co-expression information from this data set with an initial regulatory network based on a genome-wide motif scan of 652 transcription factors [22] and pairwise transcription factor protein-protein interactions (PPI) from StringDb v10 [23] (Figure 1 and Supplemental Materials and Methods). This resulted in 38 reconstructed gene regulatory networks, one for each tissue.
We used these reconstructed networks to identify tissue-specific network edges. Each PANDA network contains scores (or weights) for every possible transcription factor to gene interaction. We compared the weight of each edge in a particular tissue to the median and interquartile range of that edge's weight across all 38 tissues. Edges identified as "outliers" in a particular tissue (those with a weight in that tissue greater than the median plus two-times the interquartile range of the weight across all tissues) were designated as "tissue-specific." Using this metric we identified almost five million tissuespecific edges (28.0% of all possible edges, Supplemental Figure S1A ). Figure 2A shows the number of edges identified as specific in each of the 38 tissues, colored based on their "multiplicity," or the number of tissues in which Figure 1 : Schematic overview of our approach to characterize tissue-specific gene regulation using the GTEx expression data. We started with gene expression for 9, 435 samples across 38 tissues; the relative sample size of each of the 38 tissues in the GTEx expression data is shown in the color bar. We used PANDA to integrate this information with proteinprotein interaction and transcription factor target information (based on a genome-wide motif scan that included 652 transcription factor motifs). This produced 38 inferred gene regulatory networks, one for each tissue. We identified tissuespecific genes, transcription factors, and regulatory network edges and analyzed their properties within and across tissues.
an edge is identified as specific. We found that the majority of tissue-specific edges (62.6%) have a multiplicity of one, meaning they are uniquely identified as specific in only a single tissue. There were also many other edges that were identified as specific in two or more different tissues.
Higher edge multiplicity is often indicative of shared regulatory processes between tissues. For example, 93.4% of sigmoid colon specific edges have a multiplicity greater than one, meaning they are also called specific in other , and transcription factors (TFs, C) that were identified as "specific" to each of the 38 GTEx tissues. The total number of tissue-specific elements identified for each tissue is shown to the right of each bar (edges are shown as a multiple of 10 4 ). Tissue-specificity for network elements was defined based on an edge/node having increased weight/expression in one tissue compared to others, thus some edges, genes and TFs were identified as specific to multiple tissues. This multiplicity value is indicated by the color of the bars. We found fairly low levels of multiplicity for edges compared to nodes (TFs and genes). TFs also have substantially higher multiplicity compared to genes. Figure S2A ) indicates that 82.1% of these edges are shared with the transverse colon, 51.0% are shared with the small intestine, and 21.4% are shared with the stomach. Similarly, of those edges called specific in the basal ganglia subregion of the brain, 14.1% and 43.7% are also identified as specific in the cerebellum and other subregions of the brain, respectively.
tissues. Further investigation (Supplemental
For other tissues the composition of shared edges is quite complex. For example, 78.7% of edges identified as specific in the aorta have a multiplicity greater than one. Of these, the largest fraction is specific to the tibial artery. However, this only includes 14.8% of the aortaspecific edges; additional edges are shared with the testis (11.2%), other brain subregions (9.9%), coronary artery (9.3%), ovary (8.5%), skeletal muscle (7.7%), and the kidney (7.5%). This shows that even in cases where many of the edges identified as specific in a given tissue have a high multiplicity, as a set, these edges are often distinct from the other tissues.
Identifying Tissue-Specific Network Nodes
Since most analyses of tissue-specificity have examined gene expression, we wanted to know whether the patterns that we observed for the tissue-specific network edges could also be found in tissue-specific expression information. We identified tissue-specific network nodes (TFs and their target genes) using a process analogous to the one we used to identify tissue-specific edges. Specifically, we identified a gene (or TF) as tissue-specific if its median expression in a tissue was greater than the median plus two-times the interquartile range of its expression across all tissues. This process identified 11, 042 genes as tissue-specific (40.6% of all genes, see Supplemental Figure S1B -C); 201 of these genes code for transcription factors (33.1% of the 607 TFs that are also target genes, see Supplemental Material and Methods and Supplemental Tables 1-2).
We find that the number of genes and transcription factors identified as tissue-specific based on expression is not correlated with the number of tissue-specific edges ( Figure 2B -C). We also observe much higher multiplicity levels for network nodes than for the edges (p < 10 −15 for both genes and TFs by two-sample Chi-squared test), indicating that genes and transcription factors are more likely to be identified as "specific" in multiple tissues than are regulatory edges.
As with the edges, node-multiplicity provides insight into shared functions among the tissues. Consistent with previous findings, testis has the largest number of tissuespecific genes [24, 25] and we find that many of the genes identified as specific in other tissues are also identified as specific in the testis (Supplemental Figure S2B ). Other shared patterns of expression mirror what we observed among the network edges. For example, genes identified as specific in the basal ganglia brain subregion include those that are also identified as specific in the cerebellum (40.5%), other brain subregions (68.0%), and the pituitary gland (24.0%). Similarly, 53.2% and 33.0% of sigmoid-colon specific genes are shared with the transverse colon and the small intestine, respectively. However, these genes also include those identified as specific in the prostate (24.7%), esophagus (23.9% in the muscularis and 15.6% in the gastroesophageal junction), uterus (19.3%), vagina (13.8%), and stomach (13.8%).
The overlap of genes identified as specific in multiple tissues is quite complex and there are many cases of shared expression patterns between tissues that are not reflected in the tissue-specific network edges we had previously identified. This is especially true for the transcription factor regulators in our network model. For example, only a single transcription factor (TBX20) was identified as tissue-specific in the aorta based on our expression analysis. This transcription factor [26, 27] has a high level of multiplicity and was also identified as specific in the coronary artery, testis, pituitary, and heart (both the atrial appendage and left ventricle regions; see Supplemental Table 1 and Supplemental Figure S2C ). We find similar patterns in many of the other tissues, including the coronary artery, subcutaneous adipose, esophagus muscularis, tibial nerve, tibial artery, and the visceral adipose. Each of these tissues has only two or three associated tissue-specific transcription factors and almost all of these transcription factors have a multiplicity greater than one, meaning that they were identified as having relatively higher levels of expression in multiple different tissues.
Directly comparing the number of identified tissuespecific transcription factors and genes reveals that there are significantly fewer tissue-specific transcription factors than one would expect by chance (p = 1.9 · 10 −4 by twosample Chi-square test). In addition, transcription factor multiplicity levels are significantly higher than those of genes (p = 4.0·10 −12 by two-sample Chi-squared test). In other words, TFs are less likely to be identified as tissuespecific compared to genes based on expression profiles. These results imply that tissue-specific regulation may not be due to selective expression of transcription factors.
It should be noted that the transcription factors we identify as tissue-specific based on the GTEx expression data are substantially different than those listed in a previous publication [2] (see Supplemental Figure S3A -C) and used in other GTEx network evaluations [11] . In direct contrast to the results from this previous publication, we find that transcription factors are expressed at higher levels than non-TFs (compare Figure 3A in [2] to Supplemental Figure S3D ). This is likely due to technical differences in measuring the expression levels of genes between the two studies. Although state-of-theart at the time, the data used in the previous publication contained only two samples per tissue and was based on a microarray platform that only assayed expression for a subset of the genes used in our analysis (Supplemental Figure S3E ). The differences we find with this previous work highlight the importance of the GTEx project and the opportunity it gives us to revisit our understanding of the role of transcription factors in mediating tissuespecificity.
Characterizing Relationships between Tissue-Specific Network Elements
We tend to think about tissue-specificity in terms of gene expression. However, we know that gene expression arises from a complex set of regulatory interactions between transcription factors and their target genes. The networks inferred from the GTEx data provide us with a unique opportunity to characterize the relationship between the tissue-specific elements-edges, genes, and transcription factors-that help to define tissue phenotype and function.
To do this, we first determined the number of tissuespecific nodes (genes and transcription factors) that are connected to at least one tissue-specific edge. Overall, we found approximately 60% of tissue-specific genes are directly connected to at least one tissue-specific edge (Supplemental Table 3 ), meaning that tissue-specificity in gene expression is generally associated with tissuespecific changes in regulatory processes. In contrast, tissue-specific transcription factors are always connected to at least one tissue-specific edge, meaning that they are always associated with a tissue-specific regulatory process. In fact, we found that nearly every transcription factor is associated with at least one tissue-specific edge in all 38 tissues. This suggests that even transcription factors that are similarly expressed across tissues, and thus not identified as tissue-specific, may play an important role in mediating tissue-specific regulation.
We next quantified the association of tissue-specific edges with tissue-specific nodes. We did this by counting the number of tissue-specific edges that target a tissuespecific gene, summing over all 38 tissues, and dividing by the number one would expect by chance (Supplemental Materials and Methods). We found very high enrichment for tissue-specific edges targeting tissue-specific genes, especially for the most specific edges those with lower multiplicity values ( Figure 3A ). We repeated this calculation to evaluate whether tissue-specific edges tended to originate from tissue-specific transcription factors. Although we again observed strong enrichment ( Figure 3B ), this was substantially lower than the enrichment we observed between tissue-specific edges and genes.
Finally, because PANDA uses multiple sources of input data, we analyzed tissue-specific edges in the context of both the input co-expression data and the canonical transcription factor-target gene interactions we used to seed our networks (defined by the presence of a TF motif in the promoter region of a target gene). We found that tissuespecific edges are distinct from those identified using only co-expression information (Supplemental Figure S2D ). In addition, tissue-specific edges are depleted for canonical transcription factor interactions ( Figure 3C ). This suggests that tissue-specific regulation moves away from promoter binding-sites and relies on additional interactions that become available in a context-dependent manner. Because of this apparent move from canonical sites, many of the tissue-specific regulatory interactions we identified using PANDA would have been missed if we had relied solely upon co-expression or transcription factor motif targeting information to define a regulatory network.
Evaluating Tissue-Specific Regulation of Biological Processes
As noted previously, transcription factors are less likely than other genes to be identified as tissue-specific based on their expression profile, and even those identified as tissue-specific tend to have a high multiplicity (are specific in multiple tissues). In addition, although tissuespecific transcription factors are significantly associated with tissue-specific network edges, this association is much lower than the one between tissue-specific genes and edges. These results led us to hypothesize that both tissue-specific and non-tissue-specific transcription factors (as defined based on expression information) play an important role in mediating tissue-specific biological processes.
We selected one of the brain-tissue subregions ("Brain other") to test this hypothesis since this tissue had the second largest number of tissue-specific edges (after testis) and the majority of genes and transcription factors called as specific to this tissue are also specific in other tissues (have high multiplicity, see Figure 2 ).
We ran a pre-Ranked Gene Set Enrichment Analysis (GSEA) [28] on each transcription factor's tissue-specific targeting profile to evaluate the role of transcription factors in regulating particular biological processes (see Supplemental Material and Methods). Figure 4A shows the Gene Ontology (GO) Biological Process terms that were significantly enriched (F DR < 0.001; GSEA Enrichment Score, ES > 0.65) for tissuespecific targeting by at least one transcription factor in this brain tissue subregion. Among the significant processes are many brain-related functions, including axonogenesis, synaptic transmission, generation of neurons, regulation of neurogenesis, and neurotransmitter secretion. A hierarchical clustering (Euclidean distance, complete linkage) of GSEA enrichment profiles across all transcription factors shows regulators are generally associated with either increased or decreased targeting of genes involved in these brain-associated processes. To our surprise, the transcription factors that are positively associated with brain-related functions are not any more likely to be expressed in a tissue-specific manner than transcription factors that are not positively associated with these functions.
To ensure this result was not due to the threshold we used when identifying tissue-specific TFs, we selected the ten transcription factors with the highest and lowest expression enrichment in this brain-tissue subregion (see Supplemental Material and Methods) and performed a detailed investigation of their GSEA profiles ( Figure 4B ). NEUROD2, SCRT1, and SP8 were the top tissue-specific transcription factors with brainfunction associated targeting profiles; these TFs play important roles in brain function [29] [30] [31] . In addition, five of the highly non-tissue-specific transcription factors (based on expression)-GRHL1, KLF15, MAFA, PAX3, and TET1-have significant enrichment (F DR < 0.001 and ES > 0.65) for targeting genes with relevant brain functions. These non-brain-specific transcription factors have been shown to play an important role in neuroblastoma [32] , neuronal differentiation [33] , regulation of glucose in the brain [34, 35] , brain development [36] , and neuronal cell death [37] , respectively.
Finally, we identified 33 transcription factors that exhibit highly significant (F DR < 0.001 and ES > 0.65) differential-targeting of the identified functions. Only one of these transcription factors (RFX4) was also identified as tissue-specific based on expression analysis. When we repeated this analysis for all 38 tissues we found similar patterns, with low overlap between the transcription factors identified as tissue-specific based on expression and those that have strong patterns of differentialtargeting (Supplemental Figure S4 and Supplemental Table 4). These results indicate that transcription factors do not have to be differentially expressed to play significant tissue-specific regulatory roles. Rather, changes in their targeting patterns allow them to regulate tissuespecific biological processes.
Tissue-Specific Organization of Biological Processes
Because of the high level of multiplicity that we previously observed, especially for transcription factors (see Figure 2 ), we next examined shared functional regulation based on tissue-specific targeting patterns. Specifically, we ran GSEA on the tissue-specific targeting profile of each transcription factor in each of the 38 tissues and selected GSEA results that represented highly significant positive enrichment for tissue-specific TF-targeting (F DR < 0.001 and ES > 0.65; all results contained in Supplemental Table 5 ). We then clustered these associations [38] (see Supplemental Material and Methods) and identified 62 separate "communities," or groups of GO terms associated with TF/tissue pairs [39, 40] (Figure 5A ). Properties of the identified communities, including the number of terms, TFs, and tissues represented in each, are included in Supplemental Table 6 .
Nine communities had eight or more associated GO terms. Further inspection showed that these communities often included sets of highly related functions, such as those associated with immune response (Community 1), cell proliferation (Community 2), synaptic transmission (Community 3), muscle contraction (Community 4), epidermis development (Community 5), cellular respiration (Community 6), chromatin remodeling (Community 7), metabolic processes (Community 8), and protein modification (Community 9).
We used word clouds to summarize this information and provide a snapshot of the functions associated with each of these nine communities ( Figure 5B ; Supplemental Materials and Methods). We also examined what tissues were associated with each community and found that communities were generally dominated by enrichment for increased functional targeting in a select set of tissues ( Figure 5C ). For example, Community 1 is highly associated with the tibial and coronary arteries, Community 3 is highly associated with two of the brain subregions ("Brain other" and "Brain basal ganglia") and Community 4 is highly associated with skeletal muscle, as well as the atrial appendage of the heart and the kidney cortex. Although some of the communities represent sets of functions that are common to multiple tissues, these associations make biological sense. For example, some tissues, such as skin and whole blood, have higher rates of proliferation compared to others and so we might expect increased targeting of cell cycle functions in these tissues.
The remaining 53 communities had three or fewer GO term members but often capture important associations between tissues and biological function (Supplemental Figure S5 ). For example, Community 14 contains two GO Biological Processes term members, "digestion" and "fatty acid oxidation" and is enriched for positive tissuespecific targeting in the sigmoid colon (17 TFs), small intestine (11 TFs), stomach (1 TF), and kidney (1 TF). NR2E1  OLIG2  PAX7  SCRT1  SCRT2  SP8  TBR1  VAX1  GRHL1  HNF1A  KLF15  LBX1  MAFA  OVOL1  PAX3  POU4F2   T  TET1 AC-activating GPCR signaling development" and "spermatid differentiation" and is enriched for positive tissue-specific targeting in the testis (21 TFs). Community 27 contains exactly one GO term, "steroid biosynthetic process" and is enriched for positive tissue-specific targeting in the ovary (5 TFs, including SOX2, SOX7, SOX9, TEAD1, and ZNF410). The GO term and TF/tissue members of all communities are contained in Supplemental Table 6 .
In addition to identifying tissue-specific function, we identified several transcription factors that appear to mediate similar biological functions across multiple tissues ( Figure 5D ). For example, Community 1 (immune response) includes targeting profiles from 348 different TFs and 22 tissues (Supplemental Table 6 ). Further inspection reveals that eight transcription factors have increased targeting of Community 1 functions in four or more of these tissues. These transcription factors include MYBL1 (also known as A-MYB), which is involved in regulation of B cells [41] and YY1, which was recently reported to inhibit differentiation and function of regulatory T cells [42] .
Maintenance of Tissue-Specificity in the Global Regulatory Framework
The analysis we have presented thus far has focused primarily on tissue-specific network edges, or regulatory interactions that have an increased likelihood in one, or a small number of tissues, compared to others. However, we know that these tissue-specific interactions work within the context of a larger "global" gene regulatory network, much of which is the same in many tissues. Therefore, we investigated how tissue-specific regulatory processes are reflected in changes to the overall structure and organization of each tissue's "global" gene regulatory network.
To begin, we analyzed the connectivity of nodes separately in each of the 38 tissues' gene regulatory networks using two measures: (1) degree, or the number of edges connected to a node, and (2) betweenness [43] , or the number of shortest paths passing through a node (Figure 6A ). Because of the complete nature of the networks estimated by PANDA, we used algorithms that account for edge weight when calculating these measures [44] (see Supplemental Materials and Methods). For each tissue, we then compared the median degree and betweenness values of tissue-specific genes to the median degree and betweenness values of non-tissue-specific genes (Figure 6B ).
This analysis showed that tissue-specific genes generally have a lower degree than non-tissue-specific genes. This may initially seem contradictory to our observation that tissue-specific genes are highly targeted by tissuespecific edges ( Figure 3A ). However, we also found that tissue-specific edges tended to be associated with noncanonical regulatory events ( Figure 3C ), which generally have lower weights in our network models. The analysis presented here considers all regulatory interactions (both tissue-specific and non-tissue-specific) leading to a network whose structure is largely dominated by canonical regulatory events. Thus, we can conclude that tissuespecific genes gain targeting from tissue-specific edges, consistent with our previous finding. However, in the ; the gray-scale gradient represents the number of tissues in which the indicated TF is significantly differentially-targeting one of the GO terms associated with the community, divided by the total number of unique tissues with significant differential-targeting in that community.
context of the global gene regulatory network, the targeting of these tissue-specific genes is much lower as compared to other, non-tissue-specific genes [45] .
These findings are consistent with the notion that processes required for a large number of (or all) tissues need to be stably regulated. Thus one might expect these to be more tightly controlled and therefore central to the network. Indeed, when we examine the distributions of degree values ( Figure 6C ) we find the largest differences are between tissue-specific and non-tissue-specific genes with high degree (network hubs), with a bias for non-tissuespecific genes to have high degree values. In other words, we observe a depletion of tissue-specific genes among the gene regulatory network hubs.
Our analysis also showed that tissue-specific genes have higher median betweenness compared to non-tissue-specific genes. This indicates that tissue-specific function is likely mediated by the creation of tissue-specific regulatory paths through the global network structure, allowing increased information in the network to "flow" through tissue-specific genes despite their relatively low overall connectivity (as measured by degree). Indeed, when we examine the distribution of betweenness values ( Figure 6C ), we find that tissue-specific genes are significantly enriched for small but measurable values, while non-tissue-specific genes are more likely to have no shortest paths running through them (p < 10 −15 by one-sided Kolmogorov-Smirnov test). Rank of Gene (Percentile)   TST  BRO  KDN  BRC  CLT  BST  WBL  ARG  FIB  HRV  SPL  ITI  BRB  LCL  PRS  SKN  EMC  STM  VGN  OVR  ATT  PNC  CLS  LNG  TNV  MSG  UTR  PTT  EMS  LVR  SMU  HRA  ADS  THY  ATC  GEJ  ATA   TST  BRO  KDN  BRC  CLT  BST  WBL  ARG  FIB  HRV  SPL  ITI  BRB  LCL  PRS  SKN  EMC  STM  VGN  OVR  ATT  PNC  CLS  LNG  TNV  MSG  UTR  PTT  EMS  LVR  SMU  HRA  ADS  THY  ATC  GEJ 
DISCUSSION
We used gene expression data from GTEx, together with other sources of regulatory information, to reconstruct and characterize regulatory networks for 38 tissues and to assess tissue-specific gene regulation. We used these networks to identify tissue-specific edges and used the gene expression data to identify tissue-specific nodes (transcription factors and genes). We found that, although tissue-specific edges are enriched for connecting to tissue-specific transcription factors and genes, they are also depleted for "canonical" interactions (defined based on a transcription factor binding site in the target gene's promoter). In addition, edges are often uniquely called as specific in only one tissue while tissue-specific genes often have a high "multiplicity," meaning that they were identified as specific in more than one tissue.
In particular, we found that genes that encode for transcription factors were especially likely to be identified as specific in multiple different tissues. This suggests that the notion of a "tissue-specific" transcription factor based on expression information should be considered with care, especially in the context of transcriptional regulation. Indeed, analysis of tissue-specific targeting patterns in our regulatory networks indicated that transcription factor expression is not the primary driver of tissue-specific functions. Our network analysis found many transcription factors that are known to be involved in important tissue-specific biological processes that were not identified as tissue-specific based on their expression profiles. These findings are consistent with what we might expect [46] . There are approximately 30, 000 genes in the human genome, but fewer than 2, 000 of these encode transcription factors [2] (of which we analyzed only 652 those with high quality motif information). Given the large number of tissue-specific functions that must be regulated, it makes sense that changes in complex regulatory patterns are responsible for tissue-specific gene expression, not the activation or deactivation of individual regulators.
Our results suggest that transcription factors primarily participate in tissue-specific regulatory processes via alterations in their targeting patterns. To understand the regulatory context of these tissue-specific alterations, we investigated the topology of each of the 38 "global" tissue regulatory networks (containing information for all possible edges). We found that tissue-specific genes generally are less targeted (have a lower degree) than nontissue-specific genes. However, tissue-specific genes exhibit an increase in the number of regulatory paths running through them (have a higher betweenness) as compared to non-tissue-specific genes. These results indicate that tissue-specific regulation does not occur in dense portions of the regulatory network, or by the formation of new tissue-specific hubs. Rather, tissue-specific genes become central to the regulatory network on an intermediate scale through the creation of new, tissue-specific, regulatory paths [45] . We believe this result supports the notion that tissue-specific function is largely driven by non-canonical interactions. Such interactions could, for example, be interactions through TF complexes (no direct binding between a TF to the promoter of its target gene), binding of a TF to an alternative motif, or interactions outside of a gene's promoter (for example binding to an enhancer) [47] . This last explanation may have the most merit. If a cell were to add a new function, it would likely not do this by disruption of an existing, commonly used, adjacent regulatory region, but by gaining a new binding site outside of that window.
Overall, our analysis provides a more comprehensive picture of tissue-specific regulatory processes than reported previously. Our comparison of global gene regulatory network models across a large set of human tissues provided important insights into the complex regulatory connections between genes and transcription factors, allowed us to identify how those structures are subtly different in each tissue, and ultimately led us to better understand how transcription factors regulate the necessary tissue-specific biological processes. One important result from our analysis is that transcription factor expression information is very poorly correlated with tissue-specific regulation of key biological functions. At the same time, we find that alterations in transcription factor targeting cause the structure of each tissue's regulatory network to change, such that tissue-specific genes occupy central positions by virtue of the creation of new paths through a global network structure.
Taken together, these results support the notion that tissue-specificity requires adjusting and adapting processes rather than creating wholly new ones. In other words, tissue-specific biological function occurs as a result of building on an existing regulatory structure so that the creation of a new process shares a functional core with established processes. This overall picture is parsimonious with the evolutionary model in which nature borrows from existing structures to create new functions and to build on them. We note that the signals we observe are absent in a network constructed solely based on canonical transcription factor-target gene interactions (Supplemental Figure S6 ) suggesting that these new regulatory paths are created, in large part, by the addition of tissue-specific edges into a global regulatory network structure.
Ultimately, this work suggests that regulatory processes need to be analyzed in each relevant tissue, particularly if we hope to understand disease and development, to develop more effective drug therapies, and to understand the potential side effects of drugs outside of the target tissue. It also establishes a framework in which to think about the evolution of tissue-specific functions, one in which new processes are added to an established gene regulatory framework.
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All authors conceived of the study; ARS, JNP, KG and MLK analyzed the data; ARS, KG and MLK drafted the initial manuscript. All authors contributed to the reviewing and editing of the manuscript. All authors read and approved the final manuscript. control, gene filtering, and normalization preprocessing. Briefly, we performed principal coordinate analysis (PCoA) using Y-chromosome genes to test for sample sex-misidentification; we identified and removed GTEX-11ILO which was annotated as female but clustered with the males and was later confirmed to be an individual who underwent sex reassignment surgery (Kristin Ardlie, Broad Institute, private communication). We also used principal coordinate analysis on autosomal genes to group related body regions that had indistinguishable gene expression profiles. For example, skin samples from the lower leg (sun exposed) and from the suprapubic region (sun unexposed) shared gene expression profiles and were grouped as "skin," while the transverse and descending colon were very different and were retained as distinct tissues. Gene expression data were then normalized using qsmooth [2] which performs a sparsity aware normalization that provides comparable expression profiles across all tissues. This preprocessing resulted in a dataset of 9, 435 gene expression profiles assaying 30, 333 genes in 38 tissues from 549 individuals. More detailed information on the normalization process and a complete description of the 38 final tissues and the associated samples are described elsewhere [3] . Consistent with GTEx, genes are denoted by their Ensembl IDs.
S.2. Regulatory Network Reconstruction
We used the PANDA (Passing Attributes between Networks for Data Assimilation) network reconstruction algorithm [4] to estimate gene regulatory networks in each of the 38 GTEx tissues (see Section S.1). PANDA incorporates regulatory information from three types of data: gene expression (used to create a co-expression network), protein-protein interaction, and a "prior" network based on mapping transcription factors to their putative target genes (used to initialize the algorithm).
Additional Gene Expression Data Processing: We filtered the normalized GTEx gene expression data (see above) to retain only the 29, 242 autosomal genes. We then compared these genes with those that had a significant motif-hit in their promoter region (see below) and retained the 27, 175 autosomal genes that also had annotated motifs in their promoter. These genes were used when constructing our regulatory network models.
Prior Regulatory Network Based on Transcription Factor-Motif Information: To create a "prior" regulatory network between transcription factors and genes, we downloaded Homo sapiens transcription factor motifs with direct/inferred evidence from the Catalog of Inferred Sequence Binding Preferences CIS-BP (cisbp. ccbr.utoronto.ca, accessed: July 7, 2015). For each unique transcription factor, we selected the motif with the highest information content, resulting in a set of 695 motifs. We mapped these transcription factor position weight matrices (PWM) to the human genome (hg19) using FIMO [5] and retained highly significant matches (p < 10 −5 ) that occurred within the promoter regions of Ensembl genes (GRCh37.p13; annotations downloaded from genome.ucsc.edu/cgi-bin/hgTables, accessed: September 3, 2015); promoter regions were defined as [−750, +250] around the transcription start site (TSS). After intersection to only include autosomal genes with expression data (see above) and only transcription factors (TFs) with at least one significant promoter hit, this process resulted in an initial map of potential regulatory interactions involving 652 transcription factors targeting 27, 175 genes.
Prior Protein-Protein Interaction Network: We estimated an initial protein-protein interaction (PPI) network between all transcription factors (TFs) in our motif prior using interaction scores from StringDb v10 (string-db.org, accessed: October 27, 2015) . PPI interaction scores were divided by 1, 000 and selfinteractions were set equal to one.
Recontructing Networks using PANDA: For each of the 38 tissues, we used the GTEx gene expression data to calculate pairwise co-expression levels (based on Pearson correlation) between the 27, 175 target genes. We then used PANDA to combine this information with the prior regulatory network and protein-protein interaction network. This produced 38 regulatory networks, one for each tissue, with edges predicted between 652 transcription factors and 27, 175 target genes. PANDA returns complete, bipartite networks with edge weights similar to z-scores that represent the likelihood of a regulatory interaction. We transformed these z-scores to positive values using:
ij is the edge weight calculated by PANDA between a TF (i) and gene (j) in a particular tissue (t), and w (t) ij is the transformed edge-weight. These transformed edge weights are positive and so avoid issues related to calculating centrality measures on graph with negative edge-weights (see Section S.9); these transformed weights rather than the original PANDA weights were used in all subsequent network analyses.
S.3. Quantification of Tissue-Specificity vs Generality of Network Edges
Each of the 38 reconstructed PANDA networks contains scores, or "edge weights," for every possible transcription factor-to-gene interaction (see Section S.2). We used these edge weights to identify tissue-specific network edges. To do this, we compared the weight of an edge between a transcription factor (i) and a gene (j) in a particular tissue (t) to the median and interquartile range (IQR) of its weight across all 38 tissues:
We then defined an edge with an edge specificity score s (t) ij > N as specific to tissue t. We varied the cutoff N from 1 to 3, by steps of 0.25. Supplemental Figure S1A shows the fraction of edges that are identified as tissuespecific at each cutoff. We selected a cutoff of N = 2 to define tissue-specific edges in order to be consistent with the cutoff used to define tissue-specific nodes (see Section S.4). We also defined the "multiplicity" of an edge as:
This value represents the number of tissues in which an edge is identified as specific.
S.4. Quantification of Tissue-Specificity vs Generality of Network Nodes
We wished to know if the tissue-specific edges were a direct reflection of the underlying gene expression data, or if the networks might be providing additional insight into the tissue-specific regulation of genes. Therefore, we identified tissue-specific network nodes (TFs and their target genes) by applying an analogous definition as we used to define tissue-specific edges to the GTEx gene expression data. We compared the median expression level of a gene, j, in a particular tissue (e (t) j ), to the median and interquartile range of its expression across all samples:
We then defined a gene with gene specificity score s (t) j > N as specific to tissue t. We varied the cutoff N from 1 to 3, by steps of 0.25. Supplemental Figure S1B shows the fraction of tissue-specific genes identified at each cutoff. Based on this analysis, we selected a cutoff of N = 2 because with that cutoff approximately half of all genes are identified as tissue-specific. We also defined the "multiplicity" of a gene as:
This value represents the number of tissues in which a gene is identified as specific. In Supplemental Figure S1C we show some examples of non-tissue-specific and tissuespecific genes with different levels of multiplicity. We observe that the term "tissue-specific" is largely a misnomer. Many genes have a multiplicity greater than one, Normalized Expression
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Not Tissue-Specif c Specif c to One Tissue Specif c to >1 Tissue meaning that they are not actually "specific" to a particular tissue, but rather have a relatively higher level of expression in a subset of tissues compared to the others. Identifying Tissue-Specific Transcription Factors: Each of our network models includes information about the targeting profiles of 652 transcription factors (see Section S.2). Of those, 636 are included in the normalized GTEx expression data (see Section S.1), and 607 appear as both transcription factors and target genes in our network model (this reduction is in large part due to only including autosomal genes as targets in our network analysis, see Section S.2). In analyzing tissue-specific transcription factors (Figures 2-4 in the main text) we focus on this subset of 607 transcription factors; information for the other transcription factors can be found in Supplemental Table 1 .
S.5. Comparison of PANDA and Correlation-Based Networks
Since co-expression networks have been widely used to analyze gene expression data, including in another network analysis of tissue-specificity in GTEx [6] , we compared the tissue-specific edges defined based on PANDAnetworks to those defined based on co-expression. For each of the 38 GTEx tissues analyzed we created coexpression networks by calculating the Pearson correlation between the TFs and genes included in our network model. Since not all TFs have expression information this included edges between 636 TFs and 27, 175 target genes (see Section S.4). We identified tissue-specific edges in these correlation-based networks using same protocol we used for genes and PANDA edges (Equation S2, with N = 2). When we compared the edges identified as tissue-specific using the correlation-based networks to those identified based on the PANDA-reconstructed regulatory networks and we very little overlap (Supplemental Figure S2D) .
This low level of overlap means that PANDA and Pearson Correlation networks capture fundamentally different aspects of each tissue's gene expression program. The coexpression networks are based on measured expression correlations between TFs and their targets. In contrast, PANDA uses co-expression between all target genes (not only TFs and their targets) together with a prior regulatory network structure and TF-TF protein-protein interaction data, and iteratively updates the likelihood of an interaction between TFs and target genes in the regulatory network based on shared patterns across all of these data.
We believe that PANDA more accurately captures tissue-specific regulatory processes. Indeed, when developing PANDA, we compared it to other methods, including co-expression networks, and found that the PANDA networks were better supported by confirmatory data, such as ChIP experiments [4] . Although no ChIP data are available for GTEx, PANDA does find biologically relevant associations that help elucidate the link between expression and tissue phenotype.
S.6. Comparison with a Previously Published
Tissue-Specific TF Resource
We also compared the transcription factors we identified as tissue-specific based on the GTEx expression data (see Section S.4) with those reported as tissue-specific in Figure S2 : Percentage of (A) edges, (B) genes, and (C) TFs that were identified as specific in the tissue listed along the Y-axis, that are also identified as specific to the tissue listed along the X-axis. (D) Comparison of the tissue-specific edges identified using PANDA-networks to those that would have been identified using a network defined based on co-expression information.
a previous publication [7] (hereafter referred to as NRG, standing for the journal in which it was published: Nature Reviews Genetics) and which were used in other GTEx network evaluations [6] . The results of this analysis are shown in Supplemental Figure S3 .
To begin, we downloaded the gene expression data used for the calling of tissue-specific transcription factors in the NRG publication from the Gene Expression Omnibus (GSE1133). We RMA-normalized these expression data using the justRMA() function in the affy Version 1.52.0 library from Bioconductor in R and used a custom-CDF for the Affymetrix GeneChip HG-U133A array (hgu133ahsensgcdf 20.0.0) [8] in order to normalize with respect to current Ensembl genes IDs. This RMAnormalized version of the expression data contained expression information for 11, 900 different Ensembl genes across 158 total samples, 64 of which correspond to the "32 healthy major tissues and organs" used in the NRG analysis. 11, 363 of the genes in this RMA-normalized NRG expression data set also appeared in the normalized GTEx data (see Section S.1 and Supplemental Figure S3A ).
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Evaluating 1120 TFs Evaluating 474 TFs Tissue Name Brain other  whole brain  Brain cerebellum  whole brain  Brain basal ganglia  whole brain  Heart atrial appendage  heart  Heart left ventricle  heart  Kidney cortex  kidney  Liver  liver  Lung  lung  Minor salivary gland  salivary gland  Skeletal muscle  skeletal muscle  Ovary  ovary  Pancreas  pancreas  Pituitary  pituitary  Prostate  prostate  Skin  skin  Testis  testis  Thyroid  thyroid  Uterus  uterus  Whole blood whole blood Supplemental Figure S3 : Analysis comparing the results of from a previous publication (NRG) with those obtained in this analysis using the GTEx RNA-seq data. (A) An overview of the overlap in the genes included in the NRG gene expression data, the TFs included in the NRG supplemental data file, and how those sets overlap with the 30, 333 genes in the normalized RNAseq data we used in this analysis (see Section S.1). (B) An analysis comparing the overlap of TFs identified as specific based on the NRG publication and those identified based on the GTEx data (see Section S.4). (C) The distribution of expression values in the GTEx data for several example TFs. These TFs were chosen to illustrate a range of possibilities, including some overlap (EGR4, GATA4, ESR1), as well as opposing (XBP1), identical (PAX8), or distinct (RFX4, ZNF106, EGR1, TBX3) tissue-specific calls based on using either the NRG or the GTEx analysis. As there was little overlap between NRG and GTEx, the four plots with distinct tissue-specific calls are the most representative. (D) The expression of transcription factors versus non-transcription factor genes in both the NRG and GTEx expression data and using various criteria. (E) Information regarding the types of genes that are common between the set on the NRG microarray and in the GTEx RNA-seq data, and the types of genes that we have included in our GTEx expression analysis that were not on the NRG microarray.
We next downloaded the supplemental data that accompanied the NRG manuscript. The "supplemental information S3" file contained information for 1, 987 genes that encode transcription factors, including their "Ensembl gene IDs (release 51), HGNC identifiers, IPI IDs, associated DNA-binding Interpro domains and families, and tissue specificity if any." Of the 1, 987 transcription factors in this supplemental data file, 1, 130 were included in the RMA-normalized expression data we had downloaded from GEO and 1, 798 had expression information in the normalized GTEx data.
1, 120 of these transcription factors had gene expression values in both the RMA-normalized NRG data and the normalized GTEx data (Supplemental Figure S3A ). We evaluated how many of these transcription factors had the same tissue-specific designation in both the NRG supplemental data file and based on our analysis (see Section S.4). To do this we created a map between the 38 tissues used in our current GTEx analysis with the 32 tissues analyzed in the NRG paper. In several cases multiple different GTEx tissue subregions (eg the atrial appendage and left ventricle of the heart) were mapped to the same, more general tissue-designation in the NRG data (eg "heart"). We then directly compared the set of transcription factors that were identified as specific to a given tissue in our GTEx analysis, with the set of transcription factors that were identified as specific to that tissue in the NRG analysis.
We find that the overlap between these sets of TFs is nominally statistically significant in most cases (p < 0.05 in 14 of the 20 comparisons), however, the actual number of TFs identified as specific to a particular tissue in both the NRG and our GTEx analysis is quite low (Supplemental Figure S3B) . In fact, the lung, ovary, and pancreas contained no common tissue-specific TFs between our GTEx designation and the NRG-designation. In addition, when we restrict this analysis to the 474 of these 1, 120 TFs that were also included as regulators in our network model, even this nominal significance largely goes away.
To better understand this result, we examined the distribution of expression values in the GTEx data for these 1, 120 TFs. A few examples are included in Supplemental Figure S3C . In some cases, such as for XBP1 and TBX3, the fact that a TF was only identified as specific by NRG and not GTEx appears to be a function of the cutoff we used for defining tissue-specificity. However, we note that relaxing this criteria would have sig-nificantly changed the number of TFs we identified as tissue-specific (see Supplemental Figure S1B ) and doing so does not significantly alter the relatively low level of overlap we see here. In addition, there are many examples where our GTEx analysis clearly identifies tissuespecific signals that are not reflected in the NRG data set (ZNF106, RFX4, GATA4), and also examples where there is no apparent tissue-specific signal for a TF despite it being called so in the NRG data (EGR1, ESR1). Given that the NRG expression data contains only two samples per tissue, we are of the opinion that the tissuespecificity calls for TFs made in our analysis are more reliable.
The low level of overlap in the identified tissue-specific TFs also led us to more closely investigate the expression data used in the NRG analysis. Using the RMAnormalized NRG data (and focusing on the 11, 363 genes and 1, 120 TFs that are common between the NRG and GTEx data sets), we reproduced the plots from Figure 3 in the NRG publication. Consistent with that analysis, we find that in the NRG expression data set transcription factors are expressed at lower levels than non-TFs (compare Figure 3A in [7] to Supplemental Figure S3D ). We then repeated this same analysis using the GTEx data. To our surprise, the difference in expression between TFs and non-TFs largely disappeared when performing this analysis in the GTEx data. Finally, we repeated this analysis using all 30, 333 genes in our GTEx expression data set. This actually resulted in the opposite conclusion as the analysis presented in the NRG paper, with TFs expressed at higher levels than non-TFs.
One advantage of using RNA-sequencing data over microarrays is that sequencing can capture mRNA from many different types of genes and is not limited by the set of probes included on a given array. To better understand whether differences in technology (microarray versus RNA-sequencing) may be influencing the results shown in Supplemental Figure S3D , we next determined the annotations for the 30, 333 genes included in our GTEx analysis using Biomart (dec2013.archive.ensembl.org). Supplemental Figure S3E shows the distribution of these annotations across the 11, 363 genes that are common between the NRG microarray and the GTEx RNA-seq data, and across the 18, 970 genes that are only contained in our GTEx RNA-seq data. It is immediately clear that the microarray genes are almost completely composed of protein-coding genes whereas the genes captured only in the GTEx data contain many types, including antisense, lincRNAs and pseudogenes. Thus the fact that we see TFs expressed at higher levels than non-TFs when evaluating the full 30, 333 genes in the GTEx data is largely a consequence of the fact that all TFs are, by definition, protein-coding genes, and that protein-coding genes are expressed at higher levels than non-protein-coding genes.
Overall, this analysis highlights the importance of the public availability of data and reproducible research, as we were able to faithfully reproduce many of the results from the NRG paper using their original data. It also highlights the need to revisit previous analyses as new data becomes available. The differences in tissuespecificity and TF-expression based on the NRG analysis and the GTEx data are a perfect demonstration of the opportunity the GTEx data gives us in revisiting our understanding of tissue-specificity and gene regulation.
S.7. Calculating Enrichment of Tissue-Specific Edges
To quantify the relationship between various tissuespecific edges and nodes, we explicitly evaluated the extent to which tissue-specific edges are more (or less) likely to target tissue-specific genes (or TFs) as compared to chance. For each of the 38 tissues we counted the number of edges called as specific to a tissue (t, see Equation S2 ), and of a given multiplicity (M , see Equation S3 ) that also target a gene identified as specific to that tissue (see Equation S4 ):
We then summed these numbers over all 38 tissues:
We also calculated the number of tissue-specific edges of a given multiplicity that one would expect to target tissue-specific genes by chance:
, 175 (the number of genes in our model). Finally, we defined the enrichment for tissue-specific edges of a given multiplicity targeting tissue-specific genes as:
We found very high enrichment for tissue-specific edges targeting tissue-specific genes, especially in edges with lower multiplicity values ( Figure 3A ).
S.8. Gene Set Enrichment on TF Targeting Profiles
Gene Set Enrichment Analysis to Quantify the Functions Associated with Tissue-Specific TF-targeting: Although tissue-specific transcription factors are more likely to be associated with tissue-specific network edges than one would expect by chance, we found that this association is much lower than the association between tissue-specific edges and target genes. This led us to the hypothesis that both tissue-specific and non-tissuespecific transcription factors play an important role in mediating tissue-specific biological processes. To test this hypothesis, for each transcription factor (i), we quantified its tissue-specific targeting profile in a given tissue (t) as s
). We then ran a pre-ranked Gene Set Enrichment Analysis (GSEA) [9] on the scores in this profile to test for enrichment for Gene Ontology (GO) terms. In total we performed 24, 776 GSEA analyses, one for each of the 652 transcription factors included in the network for each of the 38 tissues. The detailed results of this analysis for each tissue are given in Supplemental Tables 4 and 5 .
Selection of TFs with Highest and Lowest Expression Enrichment: In order to better the relationship between tissue-specific transcription factor expression patterns and their tissue-specific targeting of biological functions, we selected ten transcription factors with the highest expression enrichment based on Equation S4. More specifically, for the analysis presented in Figure 4B in the main text, we selected the ten transcription factors with the highest s (Brain other) j value, and the ten transcription factors for which the absolute value of s (Brain other) j was closest to zero.
Identifying Differentially-Targeted Biological Processes and Differentially-Targeting TFs for Each Tissue: For each tissue, we identified GO terms that were significantly enriched (F DR < 0.001; GSEA Enrichment Score, ES > 0.65) for tissue-specific targeting by at least one transcription factor. This allowed us to define 38 sets of differentially-targeted biological processes, one for each tissue. For each tissue, we used the set of differentially-targeted GO terms to identify differentially-targeting TFs. More specific, for each tissue we determined the set of TFs that were specifically significantly-enriched (F DR < 0.001; GSEA Enrichment Score, ES > 0.65) for differential-targeting of at least one of the members in the complete set of differentially-targeted biological processes. This allowed us to define 38 sets of differentially-targeting TFs, one for each tissue. Interestingly, these TFs were not associated with the sets of differentially-expressed (tissue-specific) TFs identified in Section S.4 (Supplemental Figure S4) .
Community Structure Analysis to Identify Related Sets of TFs/Tissues and GO terms: To gain a more holistic understanding of the patterns of tissue-specific targeting across all 38 tissues, we combined the GSEA analysis results into a single large matrix that contained the enrichment results across all 24, 776 transcription factor and tissue pairs. This matrix contained all the tested GO terms in the rows, and each of the 24, 776 GSEA analyses in the columns. We selected elements of this matrix that represented highly significant positive enrichment for tissue-specific targeting (F DR < 10 −3 and ES > 0.65), creating a bipartite network where nodes were either GO terms or TF-tissue pairs (the pairs used for the GSEA analysis). We then ran the fast greedy community structure detection algorithm [10] to identify "communities," or sets of GO terms associated with TF-tissue pairs, in this bipartite network. The benefit of this type of analysis over other clustering approaches, such as hierarchical clustering, is that each "node" is assigned to exactly one community, aiding in our interpretation of these highly complex results. This analysis identified 62 separate communities ( Figure 5A and Supplemental Figure S5 ), or clusters of GO terms associated with TF-tissue pairs (representing the tissue-specific targeting profile of a particular TF in a particular tissue).
Word Clouds to Visualize the Functional Content of Communities: Nine communities had eight or more GO term members. For these communities we summarized their functional content using a free word-cloud making program (downloaded from:
www.softpedia. com/get/Office-tools/Other-Office-Tools/ IBM-Word-Cloud-Generator.shtml).
This program automatically configures the orientation of words in the clouds, but we manually assigned each word a relative size based on that word's statistical enrichment in the community [11] . Specifically, for a given community, we counted the number of times an individual word appeared across all the GO term members associated with that community (Nwc) and then calculated its statistical enrichment in a given community based on the hypergeometric probability:
where N c is the number of individual words in a community, N w is the number of times the word appears across all term descriptions and N tot is the total number of words included in all tested GO terms. We then scaled the sizes of the words in the word cloud based on −log 10 (p) such that words that have the lowest probability of being in the community by chance are given the largest size and words that are common across many biological functions and that one might expect to be in a community by chance are given a very small size.
S.9. Network Centrality Estimates of Tissue-Specific Genes
We used the igraph Version 1.0.0 package in R to calculate both the degree (using the graph.strength() function) and betweenness centrality (using the betweenness() function) of genes in each of the 38 complete, weighted PANDA tissue networks (see Section S.2 and Equation S1).
Degree: The degree of a node is defined as the number of edges connected to that node. Because we have weighted graphs, we calculated the degree of a gene in a given tissue (t) by summing up the weights of all edges
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Number of: Figure S4 : Comparison of TFs defined as tissue-specific based on their expression profile, versus based on their differential-targeting profile. This comparison only considered the 607 TFs that are both target genes and regulators in the network models. All TFs that have tissue-specific differential-targeting profiles can be found in Supplemental Table 4 .
connected to that gene (w (t) j see Equation S1
). Note that because these are also complete graphs, each gene had exactly 652 edges, one from each transcription factor.
Betweenness: The betweenness of a node is defined as the fraction of non-redundant shortest paths in the net-work that go through that node. In a weighted network, the shortest path calculation uses edge weights to calculate the cost of traversing each edge. In order to prefer higher edge weights in calculating shortest paths, we used 1/w (t) ij (see Equation S1) as the cost for determining the shortest paths. In order to calculate the betweenness centrality, we treated edges as undirected (meaning that an edge exists both from a TF to its target gene and from the target gene to the TF).
S.10. Network Centrality of PANDA's Seed Regulatory Network
PANDA builds its predicted regulatory network, in part, by leveraging information from a prior "seed" network constructed by mapping transcription factors to genes based on genome sequence information (see Section S.2). We wanted test whether the differences in centrality values that we observed between tissue-specific and non-tissue-specific genes were due to the structure of this input data or if they were identified primarily through PANDA's message passing network optimization. Therefore, we calculated the degree and betweenness centrality for genes based on the motif scan seed network (see Section S.9). We note that this seed network is "unweighted," meaning that the edges only take two values: one if the motif for TF i is found in the promoter region of gene j, and zero if it is not.
In the motif prior network, we saw only minimal differences between the centrality of tissue-specific and nontissue-specific genes, with tissue-specific genes having slightly lower centrality values compared to non-tissuespecific genes (Supplemental Figure S6 ). This is consistent with our finding in the main text that tissue-specific genes are generally of low betweenness and only see an increase in their betweenness in their specific tissues, and supports our interpretation that tissue specificity is associated with increased centrality in the network as genes gain new non-canonical regulatory paths.
SUPPLEMENTAL TABLE LEGENDS
Supplemental tables are available online.
• Supplemental Table 1 : Table listing the transcription factors included in our PANDA network models, including their multiplicity and tissue-specificity based on gene expression information.
• Supplemental Table 2 : Table listing the genes included in our PANDA network models, including their multiplicity and tissue-specificity.
• Supplemental Table 3 : Table listing the percentage of genes and TFs associated with a tissue-specific edge in each tissue.
• Supplemental Table 4 : Table listing each of the 38 tissues included in our analysis, the GO terms identified as having significantly increased targeting in each tissue (F DR < 10 −3 and ES > 0.65 by at least one transcription factor) and the TFs that are differentially-targeting these categories. Note that this table includes all 652 transcription factors included in our network model. However, it separately identifies TFs that we found to be differentiallytargeting but that were not included as a target gene in our network model (and therefore not included in the main text analysis or represented in Supplemental Figure S4 ).
• Supplemental Table 5 : Table listing all significant GSEA results (F DR < 10 −3 and ES > 0.65) obtained in our differential-targeting analysis.
• Supplemental Table 6 : Table listing statistics for the 62 "communities" of GO-terms and TF-tissue pairs that were identified when clustering the GSEA results. The "top category" is the GO term with the largest number of significantly associated TF-tissue pairs. The table also includes all the GO-terms and TF-tissue-pair members in each of the 62 "communities". [10] A. Clauset, M. E. J. Newman, C. Moore, "Finding community structure in very large networks," Physical review E 70, 6 (2004).
[11] K. Glass, Kimberly, M. Girvan, "Finding new order in biological functions from the network structure of gene annotations," PLoS Comput Biol 11, 11 (2015) .
